What Happened? Shares of scientific consulting firm Exponent (NASDAQ:EXPO) jumped 2.3% in the morning session after JPMorgan ...
Exponent’s revenue has grown at a CAGR of 6% while EBITDA has at 8%. This has been driven by its fantastic business model and industry tailwinds. Exponent provides highly complex consulting services ...
JP Morgan recently initiated coverage on Exponent with an Overweight/Buy rating, highlighting the firm’s position as a ...
MENLO PARK, Calif., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO), today announced that it will report Fourth Quarter and fiscal year 2025 financial results for the period ended ...
Owners notice dog keeps sitting in same spot—then uncover touching reason New virus strain spikes in 9 US states with symptoms from brain fog to persistent cough My Dad Was Gay — But Married To My Mom ...
Exponent exceeded expectations in Q4 2024, driven by robust demand in consumer electronics and utilities. CEO Catherine Corrigan emphasized that "effective resource management drove significantly ...